Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Szela Mary T. Director active across 3 companies, notably Prometheus Biosciences, Inc.. Cumulatively, 13 disclosures have been logged. Split: 5 buys · 1 sell. Total volume traded: €334k. Activity tracked since 19 May 2023. The latest transaction was filed on 30 June 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Szela Mary T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Szela Mary T is a declarant linked to TriSalus Life Sciences, Inc. (CEO and President), Absci Corp (Director), and Prometheus Biosciences, Inc. (Director). She has 13 filings in total, and across the sampled recent filings from 2023-05-19 to 2026-07-06, buys amount to EUR 318157 and sells to EUR 15501. The modal transaction nature is Attribution.